Bridging aging and colorectal cancer: Synergistic roles of inflammaging and immunosenescence
-
By
-
Zaongo, Silvere D
-
Yang, Qiyu
-
Han, Mei
-
Xi, Tianlan
-
Luo, Zilang
-
Wang, Xin
-
Yang, Jiadan
-
Ouyang, Jing
-
May 12, 2026
-
Clinical Scorecard: Connecting Aging and Colorectal Cancer: The Interplay of Inflammaging and Immunosenescence
At a Glance
| Category | Detail |
|---|
| Condition | Colorectal Cancer (CRC) |
| Key Mechanisms | Inflammaging and immunosenescence contribute to CRC risk in older adults. |
| Target Population | Older adults |
| Care Setting | Oncology |
Key Highlights
- Colorectal cancer incidence and mortality are rising in older adults.
- Inflammaging leads to a tumor-promoting microenvironment.
- Immunosenescence reduces immune surveillance and response to tumors.
- Chronic low-grade inflammation is a characteristic of aging.
- Understanding these mechanisms may aid in CRC prevention and therapy.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Elderly individuals at risk for colorectal cancer.
Insights may guide biomarker discovery and therapeutic interventions.
Clinical Best Practices
- Consider the role of inflammaging and immunosenescence in CRC risk assessment.
- Focus on the immunological framework in aging populations for CRC prevention.
Related Resources & Content
